DALLA PALMA, ANNA BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 566
EU - Europa 487
AS - Asia 228
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.298
Nazione #
US - Stati Uniti d'America 552
SE - Svezia 127
CN - Cina 113
IT - Italia 98
SG - Singapore 95
IE - Irlanda 94
DE - Germania 46
FR - Francia 36
AT - Austria 15
FI - Finlandia 15
TR - Turchia 14
CA - Canada 13
RO - Romania 12
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 10
BE - Belgio 9
GB - Regno Unito 8
IN - India 4
LT - Lituania 4
RU - Federazione Russa 3
SC - Seychelles 3
UA - Ucraina 3
EU - Europa 2
NL - Olanda 2
BG - Bulgaria 1
BZ - Belize 1
KH - Cambogia 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.298
Città #
Chandler 132
Dublin 94
Singapore 78
Ann Arbor 57
Ashburn 52
Boardman 40
Shanghai 37
New York 26
Parma 24
Marseille 23
Beijing 21
Dearborn 19
Munich 17
Bremen 16
Princeton 16
Vienna 15
Wilmington 13
Helsinki 12
Izmir 12
Abidjan 11
Nanjing 10
Brussels 9
Toronto 9
Brno 8
Des Moines 7
San Mateo 7
Dallas 6
Fairfield 6
Focsani 6
Romainville 6
Rome 6
Shenyang 6
Woodbridge 6
Bologna 5
Los Angeles 5
Modena 5
Santa Clara 5
Rho 4
Savignano sul Rubicone 4
West Jordan 4
Cesena 3
Guangzhou 3
Hangzhou 3
Hebei 3
Jinan 3
Milan 3
Nanchang 3
Norwalk 3
Ottawa 3
Reggio Emilia 3
Seattle 3
Arcevia 2
Borås 2
Changsha 2
Cornaredo 2
Florence 2
Fremont 2
Jacksonville 2
Kocaeli 2
Medesano 2
Piacenza 2
Pune 2
Taiyuan 2
Tianjin 2
Washington 2
Amsterdam 1
Aosta 1
Augusta 1
Belgrade 1
Belize City 1
Bratislava 1
Castelfranci 1
Castelfranco Emilia 1
Charlotte 1
Chengdu 1
Denver 1
Edinburgh 1
Frankfurt am Main 1
Harbin 1
Hefei 1
Huizen 1
Jiaxing 1
Kunming 1
Lagos 1
Leawood 1
Lille 1
Luxembourg 1
Manchester 1
Matera 1
Monmouth Junction 1
Montesilvano 1
Naples 1
Nerviano 1
Oslo 1
Paris 1
Phnom Penh 1
Phoenix 1
Rockville 1
San Francisco 1
Sofia 1
Totale 935
Nome #
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 101
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 100
Novel targets for the treatment of relapsing multiple myeloma 88
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 83
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 82
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 80
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 77
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 76
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 73
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 67
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 61
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 61
CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents 60
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 59
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results 57
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 56
The impact of CD56 expression in smoldering myeloma patients on early progression 44
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 29
CD38 expression by plasma cells in extramedullary multiple myeloma 24
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 23
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 18
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 15
Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation 11
Totale 1.345
Categoria #
all - tutte 6.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 7 18 13 2 20 18 5 2
2020/2021125 4 3 6 3 29 3 12 13 14 14 9 15
2021/2022134 2 5 9 12 1 2 26 18 6 3 12 38
2022/2023482 62 58 36 42 42 48 24 21 109 11 18 11
2023/2024235 8 17 3 4 22 71 19 7 6 14 19 45
2024/2025224 25 31 49 81 38 0 0 0 0 0 0 0
Totale 1.345